Xiaogang Hospital joins hands with technology giants to create a comprehensive medical testing platform with AI imaging and physiological data

As the epidemic eases, artificial intelligence (AI) becomes the next major key to impact the medical industry. Thanks to the vigorous development of science and technology, the quality of medical care has been greatly improved, and the average human life expectancy has increased from 40 years in the 19th century to 80 years in the 21st century. However, aging has become one of the most important issues in the world and also a serious challenge facing the medical industry.

Kaohsiung Xiaogang Hospital is collaborating with manufacturers such as Innovent, Global Life Sciences, and SGIC to develop a comprehensive medical testing assistance system that combines AI imaging and physiological data. This innovation is expected to bring global benefits to areas such as smart healthcare, telemedicine, acute care and long-term care.

In this cooperation, Xiaogang Hospital is responsible for the development of clinical medical projects and field demonstration, Yiyang Technology is involved in the hardware and software integration of AI smart medical assistance systems, and Shenguang Chip focuses on the development of spectral chip detection systems and the construction of smart medical big data platforms. Global Life Sciences coordinates overall promotion and marketing activities.

Hung Chih-hsing, director of Kaohsiung Siao-gang Hospital, said: “In recent years, Siao-gang Hospital has invested a lot of resources in building a smart hospital. This time, we are able to combine the strength of the industry to build a smart system that combines imaging data and physiological data, and develop clinical applications through the application of AI. This will not only save doctors' medical resources and accelerate the learning of new medical staff, but also provide more convenient and reliable medical services to the public, which is a win-win situation! "

Yiyang Technology has long been planning for the AI ​​medical market and is a leading manufacturer of medical imaging computing in China. It has also collaborated with international giants such as Intel and NVIDIA to develop medical AI technology platforms. The MD116E portable auxiliary system developed by it has been adopted by many benchmark hospitals at home and abroad. Yiyang Global General Manager Zhuang Fujun said: "Yiyang has a strong background in computer and communication technology, and its investment results in AI medical care in recent years have also been deeply recognized by the international market. This cooperation implements our diversified growth in AI medical care. We look forward to developing a more comprehensive medical assistance system by adding the collection of physiological data to our operational strategy.”

The spectral chip, the result of many years of research by Professor Ke Zhenghao, the founder of Shengguang Chip, will play an important role in collecting physiological data in this cooperation project. The rapid screening and quantitative systems developed during the epidemic have demonstrated the strong potential of spectral chips in the medical testing market. Professor Ke Zhenghao further pointed out: "Through the series of micro-spectrometers equipped with spectral chips, we can quickly, conveniently and locally obtain laboratory-like accurate test results, realizing the vision of decentralized testing. We look forward to this This collaboration can be an important milestone in moving from the GPU generation to the SPU generation!"

Wei Muzhong, the GLS spokesperson responsible for global marketing, is very optimistic about the market value of this cooperation. He believes: "The global AI smart medical market is estimated to be over US$500 billion, and testing is the starting point of medical treatment. We accurately grasp the source, and then use the computing power of AI to develop auxiliary interpretation models, so that doctors can perform medical behaviors more effectively. This This one-stop platform system will surely bring global help to telemedicine and precision medicine!"

The signing ceremony of the memorandum of cooperation among the four parties was also attended by Edward, President of the American Chamber of Commerce in Southern Taiwan, and other important domestic and foreign figures. They all hope that the results of this cooperation will become a highlight of Taiwan's medical innovation and be promoted to the international market, creating higher market benefits, benefiting the healthy life of all mankind, and rewriting the saying "Taiwan's experience benefits the world" A brilliant chapter.